Cribratge de preeclàmpsia... Hofmeyr G, Cochrane Database Syst Rev 2006 Askie LM, Lancet 2007...
Transcript of Cribratge de preeclàmpsia... Hofmeyr G, Cochrane Database Syst Rev 2006 Askie LM, Lancet 2007...
www.medicinafetalbarcelona.org/
Cribratge de preeclàmpsia
Sessió de Formació Continuada
ACMCB
Maig 2014
www.medicinafetalbarcelona.org/
Decisions que has de pendre abans
abans de fer un programa d´screening
• Perquè vols cribar
• Quin % de gestants vols considerar en risc
www.medicinafetalbarcelona.org/
Hofmeyr G, Cochrane Database Syst Rev 2006 Askie LM, Lancet 2007 Bujold E Obstet Gynecol. 2010
Calcium (in high risk population with low calcium intake 1gr/24h)
Antioxidants (no reduction and even increased complications)
Aspirin (75-300 mg/d): overall risk reduction
10%
Physiopathology There is prophylactic treatment?
www.medicinafetalbarcelona.org/
Hofmeyr G, Cochrane Database Syst Rev 2006 Askie LM, Lancet 2007 Bujold E Obstet Gynecol. 2010
Calcium (in high risk population with low calcium intake 1gr/24h)
Antioxidants (no reduction and even increased complications)
Aspirin (75-300 mg/d): overall risk reduction
before 16 weeks
10%
47%
Physiopathology There is prophylactic treatment?
www.medicinafetalbarcelona.org/
Hofmeyr G, Cochrane Database Syst Rev 2006 Askie LM, Lancet 2007 Bujold E Obstet Gynecol. 2010
Calcium (in high risk population with low calcium intake 1gr/24h)
Antioxidants (no reduction and even increased complications)
Aspirin (75-300 mg/d): overall risk reduction
before 16 weeks in high-risk women
10%
47%
60%
Physiopathology There is prophylactic treatment?
www.medicinafetalbarcelona.org/
Hofmeyr G, Cochrane Database Syst Rev 2006 Askie LM, Lancet 2007 Bujold E Obstet Gynecol. 2010
Calcium (in high risk population with low calcium intake 1gr/24h)
Antioxidants (no reduction and even increased complications)
Aspirin (75-300 mg/d): overall risk reduction
before 16 weeks in high-risk women early onset PE 80%
10%
47%
60%
Physiopathology There is prophylactic treatment?
www.medicinafetalbarcelona.org/
Duckitt K, Harrington D. Risk factors for preeclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005; 330:565
• Previous PE / antiphospholipid syndrome x8
• BMI 35 kg/m2 / Diabetes x4
• Nuliparity/ Multiples /Familiar history x3
• Age 40 y., Hypertension , renal or autoimmune disease, interpregnancy interval >10y x2
Epidemiological risk ¿What is risk?
www.medicinafetalbarcelona.org/
Cohort 2009-2013
• N=9462
– PE precoç 57 (0.6%)
– PE tardana 246 (2.6)
www.medicinafetalbarcelona.org/
TD: 45%-60% (per FP 5%-20%)
Factors epidemiològics
www.medicinafetalbarcelona.org/
1+ Major criteria Renal disease Autoimmune disease Diabetes Mellitus Chronic hypertension Previous preeclampsia 2+ Minor criteria Primiparity Multiple gestation Interpregnancy interval> 10 y Maternal age >40 y Familiar history of preeclampsia BMI > 35 kg/m²
NICE clinical guideline 107 August 2010
Epidemiological risk
www.medicinafetalbarcelona.org/
6-12 w
16-24 w
Before pregnancy
Uterine Doppler ¿What is risk?
www.medicinafetalbarcelona.org/
AAS Control OR (IC 95%)
Vanio 2/43 10/43 Ebrashy 26/74 40/65
Total (95% CI) 0.22 [0.08, 0.57]
0.1 0.2 0.5 1 2 5 10
Screening Uterine Doppler: aspirin
August 3/48 5/50
Villa 8/61 11/60
11-14 w PE
www.medicinafetalbarcelona.org/
Van den Elzen 95, Martin 01, Vainio 05, Ebrashy 05, Gómez 05, Parra 05, Plasencia 07
Limited detection rate Allows prophylactic intervention?
Detection rate for 10% FPR
PE ~25%
Early PE ~50%
11-14 w
Screening Uterine Doppler
PE
www.medicinafetalbarcelona.org/
TD: 65%-85% (per FP 5%-20%)
Factors epidemiològics
Doppler uterina
www.medicinafetalbarcelona.org/
• Cardiac output • Brain hemodynamic • Pulse wave analysis
• Blood pressure
Detection rate (10% FP)
Early PE ~50%
Maternal hemodynamic Screening
Poon LC,. Hypertensive disorders in pregnancy: screening by systolic diastolic and mean arterial pressure at 11-13 weeks. Hypertens Pregnancy. 2010;30(1):93-107
11-14 w PE
www.medicinafetalbarcelona.org/
TD: 75%-85% (per FP 5%-20%)
Factors epidemiològics
Doppler uterina
Tensió arteria
www.medicinafetalbarcelona.org/
Screening
11-14 w PE
PlGF
sFlt
Perfil angiogénico
Perfil anti-angiogénico
Marcadores Bioquímicos
PlGF
sFlt
www.medicinafetalbarcelona.org/
Early PE ~40%
Angionenic factors
Late PE ~30%
Detection rate (10% FP)
Wortelboer EJ, BJOG 2010; Audibert F AJOG 2010; Akelokar R Prenat Diagn 2011; ; ;;
Biochemical markers Screening
11-14 w PE
www.medicinafetalbarcelona.org/
TD: 80%-95% (per FP 5%-20%)
Factors epidemiològics
Doppler uterina
Tensió arteria
PlGF
www.medicinafetalbarcelona.org/
https://www.google.es/?gfe_rd=cr&ei=lkZyU__iOozmjwfI2IGACw#q=calcul
adora+gestacional
www.medicinafetalbarcelona.org/
www.medicinafetalbarcelona.org/
www.medicinafetalbarcelona.org/
www.medicinafetalbarcelona.org/
www.medicinafetalbarcelona.org/
Detection rate (5% FP) >1/75 Early PE 71%
Combined tests Screening
0 20 40 60 80 100
FP
100
80
60
40
20
0
DR
Performance of a first-trimester screening of preeclampsia in a routine care low-risk setting. Scazzocchio E AJOG 2012
www.medicinafetalbarcelona.org/
www.medicinafetalbarcelona.org/
PREECLAMPSIA PRECOÇ
…… SFlt
PlGF
-·-·-·- Ratio
www.medicinafetalbarcelona.org/ 29
www.medicinafetalbarcelona.org/
Construction cohort
(n=5170)
Validation cohort
(n=4175)
% PE 0.5% 0.7%
5% FPR-DR 69% 75%
10% FPR-DR 81% 82%
AUC 0.95 0.92
R2 36.8% 42.3
Shrinkage 5.5% (<10% Snee RD, Technometrics 1974)
Early preeclampsia: validation
www.medicinafetalbarcelona.org/
Construction cohort
(n=5170)
Validation cohort
(n=4175)
% PE 2.6% 3.4%
5% FPR-DR 24% 75%
10% FPR-DR 37% 82%
AUC 0.71 0.72
R2 10.1% 8.4%
Shrinkage 1.7% (<10% Snee RD, Technometrics 1974)
Late preeclampsia: validation